Vestal Point Capital’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,070,000
| Closed | -$4.14M | – | 87 |
|
2024
Q3 | $4.14M | Buy |
1,070,000
+620,000
| +138% | +$2.4M | 0.31% | 51 |
|
2024
Q2 | $2.31M | Buy |
450,000
+90,000
| +25% | +$463K | 0.17% | 55 |
|
2024
Q1 | $2.52M | Buy |
360,000
+339,694
| +1,673% | +$2.38M | 0.21% | 50 |
|
2023
Q4 | $180K | Buy |
+20,306
| New | +$180K | 0.02% | 47 |
|